Addressing the urgent need for antimicrobial stewardship in wound care
Given the societal value of antimicrobials and their diminishing effectiveness due to antimicrobial resistance, the WHO is now recommending member states to strengthen national stewardship. Still, there are currently no international or coordinated legislative or regulatory mandates designed to optimize the use of antimicrobials through stewardship. However, antimicrobial stewardship programmes are increasingly advocated as means to decrease misuse of antimicrobial agents.
Along with infection prevention and control, hand hygiene and surveillance, antimicrobial stewardship is considered a key strategy in local and national programmes aiming to prevent the emergence of antimicrobial resistance and decrease preventable healthcare associated infections.
EWMA is now taking action and introduces together with BSAC a tailored stewardship concept to wound care practitioners.
Antimicrobial Stewardship in Wound Management
Project period: 2014–ongoing
EWMA is continuously contributing to the EU’s commitment to face the challenges of antimicrobial resistance. A number of initiatives and publications have been successfully accomplished, and parallel to this, EWMA has been working on establishing contact and partnerships with organisations and groups that have mutual and synergistic objectives on the antimicrobial resistance agenda. We are pleased to have a long standing collaboration with the British Society for Antimicrobial Chemotherapy (BSAC). Furthermore, we are a committed member of the Antimicrobial Resistance Stakeholder Network (AMR).
The overall aim of the stewardship programme is to reduce inappropriate use of antibiotics by promoting, facilitating and teaching the use of antibiotic alternatives in wound management across all healthcare settings.
Antimicrobials and Non-healing Wounds: An Update
This upcoming EWMA Document provides an update on the controversies and hopes published in the 2013 document: Antimicrobials and Non-healing Wounds. Evidence, Controversies and suggestions. The document includes an updated algorithm on when to treat/not to treat with antibiotics, antiseptics and antimicrobial dressings.
Updated document to be published summer 2022.
- Jan Apelqvist, Sweden
- Thomas Bjarnsholt, Denmark
- Benjamin Lipsky, USA
- Karen Ousey, UK
- Edgar Peters, the Netherlands
- Sebastian Probst, Switzerland
A one-page guidance
A one-page guidance with general recommendations and implications for clinical practice will be published in connection with the above document.
The campaign is kindly supported by the following companies (unrestricted grants):